In line with this, the CCR7/CCL19/CCL21 dyad has also been implicated in various disorders characterized by inflammation and matrix remodeling such as atherosclerosis, rheumatoid arthritis and inflammatory bowel disease [9], [11], [12]. The gene discussed is CCL21; the disease is atherosclerosis.